Literature DB >> 19633854

[Metabolic myopathies - an overview].

M Lammens1, B Schoser.   

Abstract

Metabolic disorders of energy production characterise the group of rare, mainly autosomal recessively inherited metabolic muscular diseases which are often associated with multi-systemic symptoms. In this report, an update on the clinics, pathophysiology, pathomorphology and current treatment options of metabolic myopathies will be given. Beyond classic phenotypes of these disorders, one should be aware of oligosymptomatic patients who can be easily missed. The relevant gene mutations and the pathophysiology and pathomorphology they cause are now known for almost all these metabolic diseases. Establishing the correct diagnosis has become even more important since highly specific therapy options are now available for at least some of these inherited disorders, e.g. enzyme replacement therapy in Pompe disease.

Entities:  

Mesh:

Year:  2009        PMID: 19633854     DOI: 10.1007/s00292-009-1170-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  17 in total

1.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

Review 2.  Muscle glycogenoses: an overview.

Authors:  S Di Mauro
Journal:  Acta Myol       Date:  2007-07

3.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

4.  Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited.

Authors:  B G H Schoser; J Müller-Höcker; R Horvath; K Gempel; D Pongratz; H Lochmüller; W Müller-Felber
Journal:  Neuropathol Appl Neurobiol       Date:  2007-06-15       Impact factor: 8.090

5.  Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.

Authors:  B De Paepe; J Smet; M Lammens; S Seneca; J-J Martin; J De Bleecker; L De Meirleir; W Lissens; R Van Coster
Journal:  J Clin Pathol       Date:  2009-02       Impact factor: 3.411

6.  Mitochondrial creatine kinase containing crystals, creatine content and mitochondrial creatine kinase activity in chronic progressive external ophthalmoplegia.

Authors:  J Smeitink; A Stadhouders; R Sengers; W Ruitenbeek; R Wevers; H ter Laak; F Trijbels
Journal:  Neuromuscul Disord       Date:  1992       Impact factor: 4.296

7.  AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.

Authors:  Frank Hanisch; Pushpa Joshi; Stephan Zierz
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

8.  Clinical and genetic analysis of lipid storage myopathies.

Authors:  Aya Ohkuma; Satoru Noguchi; Hideo Sugie; May Christine V Malicdan; Tokiko Fukuda; Kunio Shimazu; Luis Carlos López; Michio Hirano; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

Review 9.  Therapeutic approaches in glycogen storage disease type II/Pompe Disease.

Authors:  Benedikt Schoser; Victoria Hill; Nina Raben
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 10.  Depletion of mtDNA: syndromes and genes.

Authors:  Simona Alberio; Rossana Mineri; Valeria Tiranti; Massimo Zeviani
Journal:  Mitochondrion       Date:  2006-12-05       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.